Zynerba Pharmaceuticals Inc. announced that the appointment of Richard A. Baron as vice president and chief financial officer (CFO) effective January 5, 2015. Prior to joining Zynerba, Mr. Baron served as senior vice president and CFO of Globus Medical.
Zynerba Pharmaceuticals, Inc.
Equities
ZYNE
US98986X1090
Biotechnology & Medical Research
1st Jan change | Capi. | |
---|---|---|
+26.90% | 49.18B | |
+0.99% | 42.11B | |
+50.47% | 40.37B | |
-5.26% | 28.85B | |
+13.80% | 26.09B | |
-22.32% | 18.71B | |
+7.73% | 13.26B | |
+32.50% | 12.32B | |
+0.29% | 11.99B |